Salvador Moncada

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Salvador Moncada
John Vane and Dr Salvador Moncada.jpg
Moncada with John Vane in 1960s
Born (1944-12-03)December 3, 1944
Tegucigalpa, Honduras
Fields Pharmacology
Institutions University of Manchester,[1] University College London[2][3]
Alma mater University of El Salvador, Royal College of Surgeons in London, University of London[4]
Known for Prostacyclin

Sir Salvador Moncada, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently the Director of the Institute of Cancer Sciences at the University of Manchester.[5]

In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained notoriety for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine.[6][7][8]

He is also the husband of Princess Marie-Esméralda of Belgium, who is a member of the Belgian Royal Family.

Biography[edit]

Moncada was born in Tegucigalpa, Honduras to Salvador Moncada and Jenny Seidner on December 3, 1944 but moved to El Salvador in 1948. He studied medicine at the Facultad de Medicina, Universidad de El Salvador from 1962 to 1970. In 1971 he went to London to work on a PhD with John Vane in the Department of Pharmacology in the Institute of Basic Medical Sciences, Royal College of Surgeons. After a short period of research in the University of Honduras he moved to the Wellcome Research Laboratories (Beckenham, Kent), where he became Director of Research in 1986. In 1996 he moved to University College London where he set up the Wolfson Institute for Biomedical Research in the Cruciform Building, which he directed until 2012. He was married to Dorys Lemus, a biochemistry teacher at the Medical School in El Salvador. The marriage resulted in two children, Claudia Regina (born 1966 – a G.P. who lives in London) and Salvador Ernesto (1972–1982). In 1998 he married HRH Princess Esmeralda of Belgium, youngest half-sister of King Albert II of the Belgians. They have two children, Alexandra Leopoldine (born 1998) and Leopoldo Daniel (born 2001).

Scientific contributions[edit]

His scientific career began at the Royal College of Surgeons where he collaborated in the discovery that aspirin-like drugs inhibit prostaglandin biosynthesis. This finding elucidated the mechanism by which these drugs act as analgesic, antipyretic and anti-inflammatory agents and also explained the mechanism by which they cause gastric damage. In 1975, at the Wellcome Research Laboratories, he led the team that discovered the enzyme thromboxane synthase and the vasodilator prostacyclin. This work contributed to the understanding of how low doses of aspirin prevent cardiovascular episodes such as myocardial infarction and stroke. As Director of Research at the Wellcome Research Laboratories he presided over the discovery and development of lamotrigine (an anti-epileptic compound), atovaquone (an anti-malarial) and zomig (for treatment of migraine headaches), and initiated the work that resulted in the development of lapatinib for the treatment of breast cancer. He was also responsible for the identification of nitric oxide as a biological mediator and the elucidation of the metabolic pathway leading to its synthesis. A great deal of the early work on the biological significance of nitric oxide in the cardiovascular system came from his laboratory, as well as some fundamental information about the role of nitric oxide in the peripheral and central nervous system and in cancer. His later work has focused on the areas of mitochondrial biology and cell metabolism. Most recently, his work has led to the finding of the molecular mechanism that coordinates cell proliferation with the provision of metabolic substrates required for this process.

Other interests[edit]

Moncada is interested in medical education and in the development of science and technology in Latin America. He has been a consultant of the Panamerican Health Organization (PAHO, the regional office of the WHO) and in recent years he founded Honduras Global – an international network of experts involved in supporting the development of Honduras.

Awards and honours[edit]

Moncada is an elected member of a number of international scientific societies. These include: Fellow of The Royal Society (1988); Foreign Member of the National Academy of Sciences of the United States of America (1994); Fellow of the Royal College of Physicians, London (1994) and Honorary Fellow of University College London (1999).

He has received honorary degrees from more than twenty universities, including Honorary Degree of Doctor of Science, Mount Sinai School of Medicine, New York, USA (1995); Degree of Doctor “Honoris Causa” of the University Pierre & Marie Curie, Paris, France (1997) and Honorary Degree of Doctor of Science of the University of Edinburgh, Scotland (2000).

His prizes and distinguished lectures include: The VIII Gaddum Memorial Lecture, British Pharmacological Society (1980); The Ulf von Euler Memorial Lecture, Karolinska Institute, Stockholm, Sweden (1991); The Paul Dudley White Lecture, American Heart Association, Anaheim, California, USA (1991); The Royal Medal of The Royal Society, UK (1994); The Gregory Pincus Memorial Lecture, The Worcester Foundation for Biomedical Research, Massachusetts, USA (1996); The Louis and Artur Lucian Award (jointly with Prof. R. Furchgott), McGill University, Montreal, Canada (1997); The Bayliss-Starling Prize Lecture, from The Physiological Society, UK (2000); The Gold Medal of The Royal Society of Medicine, UK (2000); Le Grand Prix Annuel Lefoulon-Delalande, from the Institut de France, France (2002); The Croonian Lecture, The Royal Society, London, UK (2005) and The Dohme Lecture, The Johns Hopkins University School of Medicine, Baltimore (2010).

In January 2010 he was awarded a Knighthood for Services to Science. In 2013 he was awarded Ernst Jung Gold Medal for Medicine (Ernst Jung Prize).

Publications[edit]

Moncada is the author of more than 500 peer-reviewed papers and highly cited reviews, including

References[edit]

  1. ^ http://www.manchester.ac.uk/research/salvador.moncada/publications
  2. ^ http://www.vrc-lab.be/sites/default/files/CV-Moncada.pdf
  3. ^ http://www.ucl.ac.uk/histmed/audio/neuroscience/moncada
  4. ^ http://www.vrc-lab.be/sites/default/files/CV-Moncada.pdf
  5. ^ http://www.manchester.ac.uk/discover/news/article/?id=11902
  6. ^ Howlett, R. (1998). "Nobel award stirs up debate on nitric oxide breakthrough". Nature 395 (6703): 625–6. doi:10.1038/27019. PMID 9790176.  edit
  7. ^ SoRelle, Ruth (1998). "Nobel Prize Awarded to Scientists for Nitric Oxide Discoveries". Circulation 98: 2365–2366. doi:10.1161/01.cir.98.22.2365. 
  8. ^ De Berrazueta, J. R. (1999). "The Nobel Prize for nitric oxide. The unjust exclusion of Dr. Salvador Moncada". Revista espanola de cardiologia 52 (4): 221–6. PMID 10217961.  edit

Further reading[edit]

External links[edit]